The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Poseida Therapeutics Inc (NASDAQ: PSTX) was $2.02 for the day, up 1.00% from the previous closing price of $2.00. In other words, the price has increased by $1.00 from its previous closing price. On the day, 0.64 million shares were traded. PSTX stock price reached its highest trading level at $2.07 during the session, while it also had its lowest trading level at $1.9525.
Ratios:
Our analysis of PSTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.18 and its Current Ratio is at 3.18. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 04, 2023, initiated with a Buy rating and assigned the stock a target price of $15.
On January 07, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $24.
On May 18, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $40.BTIG Research initiated its Buy rating on May 18, 2021, with a $40 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PSTX now has a Market Capitalization of 194907984 and an Enterprise Value of 68129040. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.01 while its Price-to-Book (P/B) ratio in mrq is 1.86. Its current Enterprise Value per Revenue stands at 1.053 whereas that against EBITDA is -0.55.
Stock Price History:
Over the past 52 weeks, PSTX has reached a high of $4.27, while it has fallen to a 52-week low of $1.54. The 50-Day Moving Average of the stock is -37.35%, while the 200-Day Moving Average is calculated to be -24.35%.
Shares Statistics:
PSTX traded an average of 751.31K shares per day over the past three months and 621420 shares per day over the past ten days. A total of 95.64M shares are outstanding, with a floating share count of 61.79M. Insiders hold about 35.96% of the company’s shares, while institutions hold 47.11% stake in the company. Shares short for PSTX as of 1711584000 were 4121739 with a Short Ratio of 5.49, compared to 1709164800 on 3449360. Therefore, it implies a Short% of Shares Outstanding of 4121739 and a Short% of Float of 5.7600003.
Earnings Estimates
Poseida Therapeutics Inc (PSTX) is currently under the scrutiny of POTX analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $154.71, with high estimates of $49.46 and low estimates of $82.46.
